Sio Gene Therapies Inc.

SIOX · NASDAQ
Analyze with AI
3/31/2022
3/31/2021
3/31/2020
3/31/2019
Assets
Cash & Equivalents$63,729$118,986$80,752$106,999
Short-Term Investments$0$0$0$0
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$8,007$13,347$4,678$7,585
Total Curr. Assets$71,736$132,333$85,430$114,584
Property Plant & Equip (Net)$3,344$1,630$2,333$1,278
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$5,871$5,871
Tax Assets$0$0$0$0
Other NC Assets$0$1,184$46$973
Total NC Assets$3,344$2,814$8,250$8,122
Other Assets$0$0$0$0
Total Assets$75,080$135,147$93,680$122,706
Liabilities
Payables$3,984$1,341$4,412$1,698
Short-Term Debt$786$311$16,312$21,182
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0-$21,182
Other Curr. Liab.$8,232$9,196$11,319$20,619
Total Curr. Liab.$13,002$10,848$32,043$43,499
LT Debt$1,730$932$79$22,994
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$1,730$932$79$22,994
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$14,732$11,780$32,122$66,493
Equity
Pref Stock$0$0$0$0
Common Stock$1$1$0$0
Retained Earnings-$862,956-$791,069-$758,644-$686,016
AOCI$337$335-$55$911
Other Equity$922,966$914,100$820,257$741,318
Total Equity$60,348$123,367$61,558$56,213
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$75,080$135,147$93,680$122,706
Net Debt-$61,213-$117,743-$64,361-$62,823